Related Experiment Video
Updated: Nov 16, 2025

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
Published on: September 28, 2022
N(6)-methyladenosine-binding protein YTHDF1 suppresses EBV replication and promotes EBV RNA decay
Tian-Liang Xia1, Xingyang Li1, Xueping Wang2
1State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.
Abstract:
N6 -methyladenosine (m6 A) modification of mRNA mediates diverse cellular and viral functions. Infection with Epstein-Barr virus (EBV) is causally associated with nasopharyngeal carcinoma (NPC), 10% of gastric carcinoma, and various B-cell lymphomas, in which the viral latent and lytic phases both play vital roles. Here, we show that EBV transcripts exhibit differential m6 A modification in human NPC biopsies, patient-derived xenograft tissues, and cells at different EBV infection stages. m6 A-modified EBV transcripts are recognized and destabilized by the YTHDF1 protein, which leads to the m6 A-dependent suppression of EBV infection and replication. Mechanistically, YTHDF1 hastens viral RNA decapping and mediates RNA decay by recruiting RNA degradation complexes, including ZAP, DDX17, and DCP2, thereby post-transcriptionally downregulating the expression of EBV genes. Taken together, our results reveal the critical roles of m6 A modifications and their reader YTHDF1 in EBV replication. These findings contribute novel targets for the treatment of EBV-associated cancers.
Insights
Epstein-Barr virus (EBV) RNA is modified by N6-methyladenosine (m6A), which the YTHDF1 protein targets for degradation. This m6A-dependent mechanism suppresses EBV replication and offers potential therapeutic targets for EBV-associated cancers.
Area of Science:
- Epigenetics and RNA biology
- Virology
- Oncology
Background:
- Epstein-Barr virus (EBV) infection is linked to nasopharyngeal carcinoma and B-cell lymphomas.
- N6-methyladenosine (m6A) is a key mRNA modification regulating gene expression and cellular functions.
- Understanding EBV's interaction with host cell machinery is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the role of m6A modification in EBV transcripts.
- To elucidate the mechanism by which m6A affects EBV replication and gene expression.
- To identify potential therapeutic targets for EBV-associated malignancies.
Main Methods:
- Analysis of m6A modification patterns in EBV transcripts from patient samples and cell lines.
- Investigating the interaction between m6A-modified EBV RNA and the YTHDF1 protein.
- Assessing the impact of YTHDF1 on EBV RNA stability and viral replication using molecular biology techniques.
Main Results:
- EBV transcripts show differential m6A modification across various infection stages and sample types.
- The YTHDF1 protein recognizes and destabilizes m6A-modified EBV RNA.
- YTHDF1 promotes EBV RNA decapping and decay by recruiting degradation complexes, suppressing viral gene expression and replication.
Conclusions:
- m6A modification and the YTHDF1 reader protein play critical roles in regulating EBV replication.
- The m6A-YTHDF1 pathway represents a novel mechanism for controlling EBV infection.
- Targeting the m6A modification or YTHDF1 could offer new therapeutic strategies for EBV-driven cancers.
Related Concept Videos
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Nonsense-mediated mRNA Decay
Viruses with RNA Genomes
RNA Stability
Nuclear Export of mRNA
Abnormal Proliferation

